SSSeyedeh Azra Shamsdin

Seyedeh Azra Shamsdin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Seyedeh Azra Shamsdin has a total of 71 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diagnostic evaluation of a new IgG kit for Helicobacter pylori: comparison with commercial kits and gold standards

    by Seyedeh Azra Shamsdin, Gholamreza Pouladfar, Hasti Samani, Mohammad Reza Fattahi, Yousef Nikmanesh, Amirhossein Kamyab

  • Open Access

    Comparison of Non-invasive Diagnostic Methods for Helicobacter Pylori Infection Before and After Treatment

    by Seyedeh Azra Shamsdin, Hossein Faramarzi, Hajar Khazraei, Fateme Zare, Amirhossein Kamyab

    Introduction: Helicobacter pylori (H. pylori) infection is a major contributor to peptic ulcer disease and other gastrointestinal disorders. The present study aimed to investigate the effect of treatment on diagnostic outcomes by comparing two non-invasive methods—the stool antigen test and the serological IgG antibody test, before and after therapy. This approach was designed to evaluate not only the diagnostic efficacy of these tools but also the changes in antibody responses following eradication treatment. Methods: This observational study was conducted from 2021 to 2022 at Shahid Motahari Clinic, affiliated with Shiraz University of Medical Sciences, Shiraz, Iran. A total of 108 patients with dyspepsia and confirmed H. pylori infection were enrolled. Diagnostic tests included stool antigen, anti-H. pylori IgG serology, and the urease breath test (UBT). Patients received standard triple therapy, with stool antigen and IgG levels measured before and one month after treatment to assess diagnostic accuracy and treatment outcomes. Results: Among 108 patients, 74% had peptic ulcer disease. The UBT showed the highest diagnostic accuracy (100% sensitivity, 94.6% specificity). Anti-H. pylori IgG serology had high sensitivity (100%) but lower specificity (66.2%). The stool antigen test demonstrated moderate accuracy. After treatment, stool antigen levels significantly decreased (from 4.2±0.64 to 2.9±0.75, P=0.03), and IgG titers declined significantly (from 54.26±3.33 to 46.51±3.22, P<0.0001). Conclusion: Our findings underscore UBT as the most accurate method and highlight the value of stool antigen testing for follow-up. Monitoring IgG titer changes may support treatment assessment when used alongside other tools, though its low specificity limits stand-alone use.

  • Open Access

    Effect of atorvastatin on pro-inflammatory cytokines during cisplatin administration; a double-blind clinical trial study

    by Seyedeh Azra Shamsdin, Nasrin Namdari, Ali Rajaei

    Introduction: The primary concern in maintaining treatment with cisplatin pertains to the occurrence of cisplatin-induced nephrotoxicity. After the administration of cisplatin, the prospective evaluation of the effects of Atorvastatin on kidney function and inflammatory mediators was conducted. Objectives: This double-blind clinical trial study was conducted in order to assess the changes in serum levels of tumor necrosis factor alpha (TNF-α)and interleukin-17A (IL-17A) after cisplatin administration and to ascertain the protective effects of atorvastatin against cisplatin nephrotoxicity due to the effect on the levels of cytokines. Patients and Methods: In this double-blind clinical trial study, 30 potential candidates for the administration of cisplatin were enrolled. Patients were subsequently categorized into two distinct groups. Group A received 40 mg/d of atorvastatin on the first day of cisplatin and continued for seven days. Group B was provided with a placebo. Following the administration of cisplatin, blood samples were collected for BUN, serum creatinine, magnesium, potassium, TNF-α, and IL-17A on days 0, 8 and 21. Results: Although there was no statistically significant difference in terms of serum urea, creatinine and glomerular filtration rate (GFR) between the two groups; however, within intra-group analysis, atorvastatin caused slower reduction of GFR compared to baseline. Though, no correlation was observed between the level of inflammatory cytokines including TNF-α and IL-17A and atorvastatin administration. Conclusion: Atorvastatin may have the ability to prevent cisplatin nephrotoxicity; however, it does not have any effect on inflammatory cytokines. Trial Registration: The trial protocol was approved by the Iranian Registry of Clinical Trial (identifier: IRCT20140605017982N2; https://en.irct.ir/trial/47349, ethical code: IR.SUMS.MED. REC.1398.024).

  • Anticancer effect of a combinatorial treatment of 5-fluorouracil and cell extract of some probiotic lactobacilli strains isolated from camel milk on colorectal cancer cells

    by Sanaz Salek, Elham Moazamian, Afshin Mohammadi Bardbori, Seyedeh Azra Shamsdin

    Colorectal cancer (CRC) has the highest mortality rate among cancer types, emphasizing the need for auxiliaries to 5-fluorouracil (5-FU) due to resistance and side effects. Metabolites produced by probiotic bacteria exhibit promising anticancer properties against CRC. In the current study, the anticancer effects of cell extract of three potential probiotic lactobacilli strains isolated from camel milk, Lactobacillus helveticus, Lactobacillus gallinarum, and Lactiplantibacillus plantarum, as well as that of the standard probiotic strain Lacticaseibacillus rhamnosus GG (LGG), on the human colon cancer cell line (HT-29) and the normal HEK293 cell line separately or in combination with 5-FU, were evaluated. This study isolated strains from camel milk and compared their probiotic properties to those of LGG. The cell viability, cell apoptosis, and Th17 cytokine production were assessed using the MTT assay, acridine orange/ethidium bromide (AO/EB) staining, and flow cytometry techniques, respectively. The cell extracts of lactobacilli strains combined with 5-FU reduced HT-29 cell viability effectively and increased cell apoptosis. Nevertheless, the cell extracts of lactobacilli strains combined with 5-FU controlled the cytotoxic impact of 5-FU on HEK-293 cell viability and reduced cell apoptosis. No significant differences were observed among the strains. Moreover, the cell extracts from the strains combined with 5-FU increased the levels of cytokines IFN-γ, TNF-α, and IL-17A, all of which contribute to immunity against tumors. The performance of the studied strains was similar to that of the standard probiotic strain (LGG). The investigation revealed that cell extracts from lactobacilli strains may serve as a promising complementary anticancer treatment.


  • The anticancer effect of potential probiotic L. fermentum and L. plantarum in combination with 5-fluorouracil on colorectal cancer cells

    by Sanaz Salek, Elham Moazamian, Afshin Mohammadi Bardbori, Seyedeh Azra Shamsdin

    5-Fluorouracil (5-FU) is an effective chemotherapy drug in the treatment of colorectal cancer (CRC). However, auxiliary or alternative therapies must be sought due to its resistance and potential side effects. Certain probiotic metabolites exhibit anticancer properties. In this study evaluated the anticancer and potential therapeutic activities of cell extracts potential probiotic strains, Limosilactobacillus fermentum and Lactiplantibacillus plantarum isolated from the mule milk and the standard probiotic strain Lacticaseibacillus rhamnosus GG (LGG) against the human colon cancer cell line (HT-29) and the normal cell line (HEK-293) alone or in combination with 5-FU. In this study, L. plantarum and L. fermentum, which were isolated from mule milk, were identified using biochemical and molecular methods. Their probiotic properties were investigated in vitro and compared with the standard probiotic strain of the species L. rhamnosus GG. The MTT assay, acridine orange/ethidium bromide (AO/EB) fluorescent staining, and flow cytometry were employed to measure the viability of cell lines, cell apoptosis, and production rates of Th17 cytokines, respectively. The results demonstrated that the combination of lactobacilli cell extracts and 5-FU decreased cell viability and induced apoptosis in HT-29 cells. Furthermore, this combination protected HEK-293 cells from the cytotoxic effects of 5-FU, enhancing their viability and reducing apoptosis. Moreover, the combination treatment led to an increase in the levels of IL-17A, IFN-γ, and TNF-α, which can enhance anti-tumor immunity. In conclusion, the cell extracts of the lactobacilli strains probably can act as a potential complementary anticancer therapy.


  • Open Access

    The anti-inflammatory effects of antidepressants on colitis

    by Hajar Khazraei, Seyedeh Azra Shamsdin

    Clomipramine (tricyclic antidepressant), Risperidone (a non-typical antidepressant), and Escitalopram (selective serotonin reuptake inhibitor antidepressant) might be good candidates for investigating the anti-colitis activity. The incidence of depression with ulcerative colitis in patients has led to the use of antidepressants in their treatment. In addition to the antidepressant effect of these drugs, anti-inflammatory effects have also been reported. In this study, 36 rats were used 2 ml of 3% acetic acid solution rectally to show the colitis. Then, Clomipramine (25 mg/kg), Escitalopram (10 mg/kg), Prednisolone (5 mg/kg), Risperidone (2 mg/kg), and normal saline as the control was administered orally for six days. The levels of Tumor Necrosis factor-alpha (TNF-α), Interleukin-6 (IL-6), and myeloperoxidase (MPO) were measured by Enzyme-linked immune sorbent assay (ELISA), and changes in the tissue pathology were investigated. IL-6 level was significantly reduced after the administration of clomipramine and Prednisolone (p=0.025). Risperidone has significantly reduced MPO activity in colonic tissue (P=0.006). We did find no statistical decrease in MPO activity and TNF-α and IL-6 levels after consumption of Escitalopram (p>0.05). Clomipramine showed the best anti-inflammatory effect compared to Escitalopram and Risperidone. Therefore, clomipramine showed the best relieving effect on inflammation of ulcerative colitis in rats.


  • In Vitro Cytotoxicity and Apoptotic Assay of Eucalyptus globulus Essential Oil in Colon and Liver Cancer Cell Lines

    by Hajar Khazraei, Seyedeh Azra Shamsdin, Mozhdeh Zamani

    Purpose Toxic effects of vegetables have been the subject of numerous investigations in recent years. Eucalyptus globulus of the Myrtaceae family has been traditionally used in the treatment of various infectious disorders. This study aims to assay the potential anticancer effect of Eucalyptus globulus essential oil, in vitro, and compare its cytotoxic effects on cancerous and non-cancerous cell lines. Methods The cytotoxicity of the Eucalyptus globulus essential oil was evaluated in colon cancer cell line SW48, liver cancer cell line HepG2, HEK293t, and skin fibroblast using the MTT assay. We used 5-FU as the control treatment for cancer. The essential oil was diluted by phosphate buffer saline in cell culture. Results Eucalyptus globulus essential oil with the concentration of 0.01% did not reduce the cell viability of SW48 (IC50 = 0.2%) and fibroblast cells (IC50 = 5%) after a 48-h treatment period. Eucalyptus globulus essential oil did not also exhibit any toxic effects on HEK293t and HEPG2 cell lines, except in high dose (0.5%) with IC50 = 0.2% for both of the cell lines. Conclusion Eucalyptus essential oil showed some side effects and might not be safe to use for treatment at high doses (0.5% and 5%). Moreover, the findings of the present study show that eucalyptus essential oil suppressed the proliferation of human colon cancer cells by inducing apoptosis. Eucalyptus essential oil might be a good candidate for the treatment of colon cancer.


  • Significance of TC9 and TH9 in Helicobacter pylori‐induced gastritis

    by Seyedeh Azra Shamsdin, Abdolvahab Alborzi, Abbas Ghaderi, Kamran B. Lankrani, Gholam Reza Pouladfar

    Background: H pylori plays a critical role in the development of stomach cancer, especially in people affected by the bacteria at an early stage of life. Th9 cells and IL‐9 play major roles in immune responses against various infections. IL‐9 is influential in chronic or acute inflammation of the mucosa.Aim: This study seeks to investigate the possible functions of Tc9, Th9 cells, and IL‐9 level in patients with inflammation due to H pylori infection.Methods: Eighty‐three patients with dyspepsia symptoms and twenty normal subjects with no sign and symptoms of dyspepsia were recruited. Frequencies of T‐cell subsets were determined by flow cytometry. Levels of cytokines IL‐9 family in the sera and supernatants of antigen‐activated PBMCs patients were measured by ELISA and flow cytometry.Results: The participants included 56 females and 47 males with a mean age of 39.2 ± 15.3 years. We assigned the infected group into peptic ulcer and gastritis (chronic active and chronic). Frequencies of Tc9, Th17, Tc17, Th17/9, and Tc17/9 increased significantly in the peptic ulcer, chronic active, and chronic gastritis, compared with the uninfected and healthy control groups. A significant increase was seen in IL‐9, IL‐4, and IL‐23 in the chronic active gastritis. Further observed was a significant increase in IL‐21 and a decrease in IL‐10 in the infected groups.Conclusion: The results revealed that increased Tc9, Th17/9, and Tc17/9 cells appear to be influential in the progression and severity of H pylori infection. Also, increased IL‐9 and IL‐4 levels and Tc9, Tc17/9, and Th17/9 were seen in chronic active gastritis patients. These findings may provide useful information for a therapeutic targeting of chronic active H pylori infections.


  • Open Access

    Evaluation of VEGF, FGF and PDGF and Serum Levels of Inflammatory Cytokines in Patients with Glioma and Meningioma in Southern Iran

    by Seyedeh Azra Shamsdin, Ali Mehrafshan, Seyed Mohammad Rakei, Davood Mehrabani

    Background: Meningioma and glioma are common central nervous system tumors. Hypoxic tumor cells secrete angiogenic cytokines, such as vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF) and basic fibroblast growth factor (bFGF) that stimulate neovascular formation and inflammatory cytokine, such as TNF-α and IL-1β. We measured these serum levels in patients with glial cell tumors and meningioma. Materials and Methods: This was a case-control study in 2014-2015 on patients diagnosed with meningioma/glioma. All demographic and clinical data were registered. The tumor volume and intraoperative bleeding were recorded. Serum levels of VEGF, PDGF, FGF, TNF-α and IL-1β were measured by ELISA methods. Results: Ninety-six patients were enrolled in this study, 32 in each group. Patients VEGF level with cranial tumor, glioma/meningioma had increased. VEGF level was highest among grade IV tumors, larger tumors, and in glioblastoma multiform. There was an upsurge in VEGF serum level as glioma grade increased. The highest VEGF levels were seen in parasagittal meningioma. In contrast to VEGF, PDGF was slightly elevated in glial cell tumors, which was significantly elevated in meningioma. Higher PDGF correlated with increased intraoperative bleeding, especially in meningioma cases. Oligodendroglial tumors expressed higher PDGF levels in contrast to other glial tumors. FGF level was not statistically significant. TNF-α and IL-1β expressions were significantly higher in the meningioma and glioma group in comparison to control group. Conclusion: We found increased VEGF and PDGF serum levels in CNS patient’s tumor. A different role for PDGF was found in the pathogenesis of neovascularization of meningioma, as well as oligodendroglioma. No significant result was found for FGF. TNF-α and IL-1β can serve as key prognostic biomarker in high-grade glioma and meningioma patients.


  • Open Access

    Comparison of Interleukin-33 Serum Levels in Asthmatic Patients with a Control Group and Relation with the Severity of the Disease

    by Tooba Momen, Hamid Ahanchian, Mohsen Reisi, Seyedeh Azra Shamsdin, Armindokht Shahsanai, Majid Keivanfar

    Background: The relation between interleukin-33 (IL-33) and asthma is not precisely known yet. The present study set to compare the serum level of IL-33 in patients with asthma and controls and study the relation with the severity of disease. Methods: The serum level of IL-33 and total IgE in 89 asthmatic patients and 57 controls were analyzed. The association of levels of IL-33 with the severity of disease, levels of total IgE, measures of spirometry (forced expiratory volume in 1 s [FEV1]), age, sex, presence or absence of other allergic diseases, and the disease duration was evaluated. Results: Higher levels of IL-33 and total IgE were detected in asthmatic patients compared with controls (P = 0.0001 and P = 0.008, respectively). In the asthmatic group, a significant direct association of IL-33 with age (P = 0.02, R = 0.23) and with total IgE level (P = 0.003, R = 0.31) were observed, but there was no relationship between other variables. Comparison of mean level of IL-33 in different asthma groups concerning the disease severity showed the statistically significant difference between them and a significant increased serum level of total IgE was observed in more severe disease. The results showed a significant negative correlation between FEV1 and total IgE (P = 0.028, R = −0.23) and IL-33 level (P = 0.0001, R = −0.83). Conclusions: IL-33 is suggested as a new inflammatory marker of severe and refractory asthma. Therefore, it may be a unique therapeutic target in these patients.